365 related articles for article (PubMed ID: 27567086)
21. Ocular preservation in patients with bilateral retinoblastoma before chemotherapy in situ era: A report from a Mexican Retinoblastoma Reference Hospital.
Del Carmen Bernal-Díaz Z; Murillo-Maldonado MA; Pérez-Villanueva H; Reyes-López A; Ramírez-Ortiz MA
Pediatr Blood Cancer; 2020 Oct; 67(10):e28625. PubMed ID: 32743978
[TBL] [Abstract][Full Text] [Related]
22. Mortality from second tumors among long-term survivors of retinoblastoma.
Eng C; Li FP; Abramson DH; Ellsworth RM; Wong FL; Goldman MB; Seddon J; Tarbell N; Boice JD
J Natl Cancer Inst; 1993 Jul; 85(14):1121-8. PubMed ID: 8320741
[TBL] [Abstract][Full Text] [Related]
23. Risk of subsequent malignant neoplasms in long-term hereditary retinoblastoma survivors after chemotherapy and radiotherapy.
Wong JR; Morton LM; Tucker MA; Abramson DH; Seddon JM; Sampson JN; Kleinerman RA
J Clin Oncol; 2014 Oct; 32(29):3284-90. PubMed ID: 25185089
[TBL] [Abstract][Full Text] [Related]
24. Second malignancies after Ewing's sarcoma: radiation dose-dependency of secondary sarcomas.
Kuttesch JF; Wexler LH; Marcus RB; Fairclough D; Weaver-McClure L; White M; Mao L; Delaney TF; Pratt CB; Horowitz ME; Kun LE
J Clin Oncol; 1996 Oct; 14(10):2818-25. PubMed ID: 8874344
[TBL] [Abstract][Full Text] [Related]
25. Variation of second cancer risk by family history of retinoblastoma among long-term survivors.
Kleinerman RA; Yu CL; Little MP; Li Y; Abramson D; Seddon J; Tucker MA
J Clin Oncol; 2012 Mar; 30(9):950-7. PubMed ID: 22355046
[TBL] [Abstract][Full Text] [Related]
26. Current concepts for diagnosis and treatment of retinoblastoma in Germany: aiming for safe tumor control and vision preservation.
Temming P; Lohmann D; Bornfeld N; Sauerwein W; Goericke SL; Eggert A
Klin Padiatr; 2012 Oct; 224(6):339-47. PubMed ID: 23143761
[TBL] [Abstract][Full Text] [Related]
27. Subsequent malignant neoplasms in the pediatric age in retinoblastoma survivors in Argentina.
Villanueva G; Sampor C; Moreno F; Alderete D; Moresco A; Pinto N; Szijan I; Schaiquevich P; Felice MS; Rose A; Zubizarreta P; Sgroi M; Fandiño A; Chantada G
Pediatr Blood Cancer; 2022 Aug; 69(8):e29710. PubMed ID: 35451226
[TBL] [Abstract][Full Text] [Related]
28. Non-ocular tumours following retinoblastoma in Great Britain 1951 to 2004.
MacCarthy A; Bayne AM; Draper GJ; Eatock EM; Kroll ME; Stiller CA; Vincent TJ; Hawkins MM; Jenkinson HC; Kingston JE; Neale R; Murphy MF
Br J Ophthalmol; 2009 Sep; 93(9):1159-62. PubMed ID: 19704040
[TBL] [Abstract][Full Text] [Related]
29. Second primary tumors in retinoblastoma survivors: a study of 7 Asian Indian patients.
Kaliki S; Palkonda VAR
Int Ophthalmol; 2020 Dec; 40(12):3303-3308. PubMed ID: 32737729
[TBL] [Abstract][Full Text] [Related]
30. Radiotherapy, alkylating agents, and risk of bone cancer after childhood cancer.
Hawkins MM; Wilson LM; Burton HS; Potok MH; Winter DL; Marsden HB; Stovall MA
J Natl Cancer Inst; 1996 Mar; 88(5):270-8. PubMed ID: 8614005
[TBL] [Abstract][Full Text] [Related]
31. Outcome of second malignancies after retinoblastoma: a retrospective analysis of 25 patients treated at the Institut Curie.
Aerts I; Pacquement H; Doz F; Mosseri V; Desjardins L; Sastre X; Michon J; Rodriguez J; Schlienger P; Zucker JM; Quintana E
Eur J Cancer; 2004 Jul; 40(10):1522-9. PubMed ID: 15196536
[TBL] [Abstract][Full Text] [Related]
32. Risk of new cancers after radiotherapy in long-term survivors of retinoblastoma: an extended follow-up.
Kleinerman RA; Tucker MA; Tarone RE; Abramson DH; Seddon JM; Stovall M; Li FP; Fraumeni JF
J Clin Oncol; 2005 Apr; 23(10):2272-9. PubMed ID: 15800318
[TBL] [Abstract][Full Text] [Related]
33. Second nonocular tumors in survivors of bilateral retinoblastoma: a possible age effect on radiation-related risk.
Abramson DH; Frank CM
Ophthalmology; 1998 Apr; 105(4):573-9; discussion 579-80. PubMed ID: 9544627
[TBL] [Abstract][Full Text] [Related]
34. Treatment of retinoblastoma: The Institut Curie experience on a series of 730 patients (1995 to 2009).
Lumbroso-Le Rouic L; Savignoni A; Levy-Gabriel C; Aerts I; Cassoux N; Salviat F; Gauthier-Villars M; Freneaux P; Brisse H; Dendale R; Esteve M; Doz F; Desjardins L
J Fr Ophtalmol; 2015 Jun; 38(6):535-41. PubMed ID: 25976136
[TBL] [Abstract][Full Text] [Related]
35. Neoadjuvant/adjuvant treatment of high-risk retinoblastoma: a report from the German Retinoblastoma Referral Centre.
Künkele A; Wilm J; Holdt M; Lohmann D; Bornfeld N; Eggert A; Temming P; Schulte JH
Br J Ophthalmol; 2015 Jul; 99(7):949-53. PubMed ID: 25583279
[TBL] [Abstract][Full Text] [Related]
36. [Treatment modalities and results of comprehensive therapy for extended retinoblastoma in children].
Belkina BM; Durnov LA; Poliakov VG; Goldobenko GV; Glekov IV; Ushakova TL
Vopr Onkol; 1997; 43(4):435-9. PubMed ID: 9381699
[TBL] [Abstract][Full Text] [Related]
37. Cancer mortality in long-term survivors of retinoblastoma.
Marees T; van Leeuwen FE; de Boer MR; Imhof SM; Ringens PJ; Moll AC
Eur J Cancer; 2009 Dec; 45(18):3245-53. PubMed ID: 19493675
[TBL] [Abstract][Full Text] [Related]
38. Radiation dose, chemotherapy and risk of osteosarcoma after solid tumours during childhood.
Le Vu B; de Vathaire F; Shamsaldin A; Hawkins MM; Grimaud E; Hardiman C; Diallo I; Vassal G; Bessa E; Campbell S; Panis X; Daly-Schveitzer N; Lagrange JL; Zucker JM; Eschwège F; Chavaudra J; Lemerle J
Int J Cancer; 1998 Jul; 77(3):370-7. PubMed ID: 9663598
[TBL] [Abstract][Full Text] [Related]
39. Second malignant neoplasms in long-term survivors of osteosarcoma: Memorial Sloan-Kettering Cancer Center Experience.
Aung L; Gorlick RG; Shi W; Thaler H; Shorter NA; Healey JH; Huvos AG; Meyers PA
Cancer; 2002 Oct; 95(8):1728-34. PubMed ID: 12365021
[TBL] [Abstract][Full Text] [Related]
40. Long-Term Risk of Subsequent Malignant Neoplasms After Treatment of Childhood Cancer in the DCOG LATER Study Cohort: Role of Chemotherapy.
Teepen JC; van Leeuwen FE; Tissing WJ; van Dulmen-den Broeder E; van den Heuvel-Eibrink MM; van der Pal HJ; Loonen JJ; Bresters D; Versluys B; Neggers SJCMM; Jaspers MWM; Hauptmann M; van der Heiden-van der Loo M; Visser O; Kremer LCM; Ronckers CM;
J Clin Oncol; 2017 Jul; 35(20):2288-2298. PubMed ID: 28530852
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
